(Q44173664)

30 November 2017

title

Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy (English)

1 reference

30 November 2017

1 reference

1 reference

2

1 reference

30 November 2017

10

Gen Sobue

1 reference

30 November 2017

Masahisa Katsuno

1

1 reference

30 November 2017

Akito Kume

3

1 reference

30 November 2017

Mei Li

4

1 reference

30 November 2017

Yuji Nakagomi

5

1 reference

30 November 2017

Hisayoshi Niwa

6

1 reference

30 November 2017

Chen Sang

7

1 reference

30 November 2017

Yasushi Kobayashi

8

1 reference

30 November 2017

Manabu Doyu

9

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

843-854

1 reference

Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Decrease in androgen binding and effect of androgen treatment in a case of X-linked bulbospinal neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Trinucleotide repeat length instability and age of onset in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy)

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Defects of androgen receptor function: from sex reversal to motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

CREB-binding protein sequestration by expanded polyglutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Toward an understanding of polyglutamine neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Nuclear targeting of mutant Huntingtin increases toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Lessons from animal models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

X-linked recessive bulbospinal neuronopathy. A clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

Glutamine repeats and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2802%2900834-6

7 January 2021

10.1016/S0896-6273(02)00834-6

Identifiers

DOI

1 reference

30 November 2017

1 reference